key articles
Use of the Prostate-Specific Antigen Test among U.S. Men
Monday, 19 May 2008 - Although evidence that prostate cancer deaths are reduced by screening for elevated prostate-specific antigen (PSA) concentration coupled with early diagnosis and treatment is insufficient to advocate...
Authors: Ross et al.
Prostate cancer, serum parathyroid hormone, and skeletal metastases progression
Monday, 19 May 2008 - Bony metastases from prostate cancer are a significant cause of morbidity and mortality. These metastases are predominantly blastic (bone-forming) and commonly cause increased serum levels of parathyroid...
Authors: Schwartz
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring
Saturday, 17 May 2008 - In a review, Lilja et al. (2008) examined current evidence for the association between prostate-specific antigen (PSA) and prostate cancer risk, disease outcome and recurrence. The authors also...
Authors: Lilja et al.
Sex hormone-binding globulin to predict extraprostatic tumor extension of prostate cancer patients
Friday, 16 May 2008 - Lee et al. (Lee et al., 2008) investigated the relationships of serum sex hormone-binding globulin (SHBG) level with known prognostic factors for prostate cancer in men who received radical retropubic...
Predicting the Probability of Deferred Radical Treatment for Localised Prostate Cancer
Friday, 16 May 2008 - Outcome data from a prospective study of active surveillance of localised prostate cancer were analysed by van As et al. (2008) to identify factors, present at the time of diagnosis, that predict...
Authors: van As
Prostate-specific antigen velocity and prostate cancer distant metastases
Thursday, 15 May 2008 - In men with prostate cancer, pretreatment prostate-specific antigen velocity (PSAV) is a predictor of biochemical and survival outcomes in patients undergoing radical prostatectomy (RP). The utility of...
Authors: Palma et al.
The prognostic role of the pathological T2 subclassification for prostate cancer
Wednesday, 14 May 2008 - Van Oort et al. (2008) evaluated the prognostic role of the 2002 Tumour-Nodes-Metastasis (TNM) pT2 subclassification for biochemical recurrence (BCR) after radical prostatectomy (RP) for prostate...
Authors: van Oort
Progression after radical prostatectomy for men in their thirties compared to older men
Wednesday, 14 May 2008 - Loeb et al. (2008) assessed the biochemical outcome after radical prostatectomy (RP) specifically for men aged 30-39 years, as previous studies suggest that prostate cancer in young men might be more...
Authors: Loeb et al.
Prostate-specific antigen velocity thresholds in clinical practice
Tuesday, 13 May 2008 - Connolly et al. (2008) investigated the ability of prostate-specific antigen velocity (PSAV) to predict prostate cancer, and assess the test characteristics of several PSAV thresholds for identifying...
Authors: Connolly et al.
Better androgen deprivation therapy for prostate cancer
Tuesday, 13 May 2008 - Anderson et al. (2008) addressed future needs of better androgen deprivation therapy for prostate cancer. Gonadotrophin-releasing hormone (GnRH) agonists are currently the mainstay in the management of...
Authors: Anderson et al.
